-
November 16, 2012
We are reverting to a Neutral recommendation on Alkermes plc (ALKS) from Outperform as we believe that the stock is ...
-
November 07, 2012
PDL BioPharma Inc. (PDLI) posted third-quarter earnings of 32 cents per share, in line with the Zacks Consensus ...
-
November 07, 2012
Alnylam Pharmaceuticals Inc.'s (ALNY) third quarter 2012 net loss of 38 cents per share was wider than the year-ago ...
-
November 05, 2012
Teva has restructuring and growth opportunities, but the risk is still elevated.
-
November 02, 2012
Acorda Therapeutics Inc. (ACOR) reported third quarter earnings (including share-based compensation charges but ...
-
October 26, 2012
Swiss pharmaceutical giant Novartis (NVS) reported third quarter 2012 earnings per share of $1.01, down 1% from the ...
-
October 25, 2012
Biogen Idec (BIIB) reported third quarter earnings per share of $1.90, well above the Zacks Consensus Estimate of ...
-
October 25, 2012
Elan Corporation's (ELN) loss of 5 cents per share (excluding special items) for the second quarter of 2012 was ...
-
October 25, 2012
The Medicines Company (MDCO) reported third quarter earnings of 32 cents per share, well above the year-ago earnings ...
-
October 25, 2012
Biogen Idec (Nasdaq:BIIB) announced its results for the most recent quarter on October 25, 2012. Biogen Idec is a ...
-
October 24, 2012
Sanofi (SNY) and its subsidiary Genzyme recently presented positive data on its oral treatment for relapsing forms ...
-
October 23, 2012
Acorda Therapeutics Inc. (ACOR) recently announced that its patent no. 5,540,938 has been granted a five year patent ...
-
October 22, 2012
On Thursday, October 25, 2012, Biogen Idec (Nasdaq:BIIB) will report its third quarter earnings. A business' ...
-
October 19, 2012
Biogen Idec's (BIIB) shares were down 2.74% after the company announced that the US Food and Drug Administration ...
-
October 19, 2012
Abbott Laboratories (ABT) and its partner Reata Pharmaceuticals, Inc. recently announced the discontinuation of the ...
-
October 18, 2012
We recently initiated coverage on commercial-stage biopharmaceutical company Acorda Therapeutics, Inc. (ACOR) with a ...
-
October 18, 2012
The Nasdaq has decreased 0.3%, the S&P 500 has moved little and the Dow has climbed 0.1% so far today. The ...
-
October 17, 2012
Abbott Labs (ABT) reported third quarter earnings of $1.30 per share, a couple of cents above the Zacks Consensus ...
-
October 12, 2012
Novartis AG (NVS) recently announced results from two large phase III studies of its multiple sclerosis (MS) drug ...
-
October 12, 2012
Elan Corporation (ELN) and partner Biogen Idec (BIIB) recently presented data from 11 company-sponsored Tysabri ...
